Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy

Detalhes bibliográficos
Autor(a) principal: Daher,Silvia
Data de Publicação: 1997
Outros Autores: Fonseca,Flavia, Mattar,Roseane, Musatti,Chloe Camba, Lima,Maria Gerbase de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000400006
Resumo: INTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients.
id APM-1_fa208211fb9a0daf4ea1bb30a2a5a725
oai_identifier_str oai:scielo:S1516-31801997000400006
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancyMixed lymphocyte culture testPregnancyHabitual abortionINTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients.Associação Paulista de Medicina - APM1997-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000400006Sao Paulo Medical Journal v.115 n.4 1997reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31801997000400006info:eu-repo/semantics/openAccessDaher,SilviaFonseca,FlaviaMattar,RoseaneMusatti,Chloe CambaLima,Maria Gerbase deeng2008-11-05T00:00:00Zoai:scielo:S1516-31801997000400006Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2008-11-05T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
title Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
spellingShingle Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
Daher,Silvia
Mixed lymphocyte culture test
Pregnancy
Habitual abortion
title_short Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
title_full Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
title_fullStr Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
title_full_unstemmed Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
title_sort Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
author Daher,Silvia
author_facet Daher,Silvia
Fonseca,Flavia
Mattar,Roseane
Musatti,Chloe Camba
Lima,Maria Gerbase de
author_role author
author2 Fonseca,Flavia
Mattar,Roseane
Musatti,Chloe Camba
Lima,Maria Gerbase de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Daher,Silvia
Fonseca,Flavia
Mattar,Roseane
Musatti,Chloe Camba
Lima,Maria Gerbase de
dc.subject.por.fl_str_mv Mixed lymphocyte culture test
Pregnancy
Habitual abortion
topic Mixed lymphocyte culture test
Pregnancy
Habitual abortion
description INTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients.
publishDate 1997
dc.date.none.fl_str_mv 1997-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000400006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000400006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31801997000400006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.115 n.4 1997
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209259576360960